ANALYSIS OF THE INFLUENCE OF GENETIC FACTORS OF HEPATITIS C VIRUS AND GENE POLYMORPHISM IN INFECTED PATIENTS ON THE DEVELOPMENT OF LIVER FIBROSIS
- Authors: Nikolaeva L.I.1, Kolotvin A.V.1, Samokhodskaya L.M.2, Sapronov G.V.3, Makashova V.V.4, Samokhvalov E.I.1, Al’khovsky S.V.1, Grishechkin A.E.1, Belyaeva N.M.3, Gibadulin R.A.1
-
Affiliations:
- Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federation
- Federal State Educational Institution ofHigher Professional Education M.V Lomonosov, Moscow State University
- State Budgetary Educational Institution of Additional Professioinal Education Russian Medical Academy of Postgraduate Education
- Federal Budget Institution of Science Central Research Institute of Epidemiology of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance
- Issue: Vol 17, No 5 (2012)
- Pages: 7-13
- Section: Articles
- URL: https://journals.rcsi.science/1560-9529/article/view/40683
- DOI: https://doi.org/10.17816/EID40683
- ID: 40683
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
L. I. Nikolaeva
Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federation
Email: L.I.Nikolaeva@mail.ru
д-р биол. наук, вед. науч. сотр. лаб. генно-инженерных препаратов Moscow, Russian Federation, 16, Ulitsa Gamalei, 123098
A. V. Kolotvin
Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federationнауч. сотр. МГУ им. М.В. Ломоносова, ГУНУ фак-т фундаментальной медицины, НИИ вирусологии им. Д.И. Ивановского, лаб. генно-инженерных препаратов Moscow, Russian Federation, 16, Ulitsa Gamalei, 123098
L. M. Samokhodskaya
Federal State Educational Institution ofHigher Professional Education M.V Lomonosov, Moscow State Universityканд. мед. наук; доц., ст. науч. сотр. МГУ им. М. В. Ломоносова, ГУНУ фак. фундаментальной медицины, лаб. генных и клеточных технологий 1, Vorobyovy gory, Moscow, Russian Federation, 119991
G. V. Sapronov
State Budgetary Educational Institution of Additional Professioinal Education Russian Medical Academy of Postgraduate Educationканд. мед. наук, доцент каф. инфекционных болезней ГБОУ ДПО РМАПО 2/1, Ul. Barrikadnaya, Moscow, Russian Federation, 123995
V. V. Makashova
Federal Budget Institution of Science Central Research Institute of Epidemiology of The Federal Service on Customers' Rights Protection and Human Well-being Surveillanceд-р мед. наук, проф., вед. науч. сотр ЦНИИ эпидемиологии, клинич. отд-ния инфек. патологии 3a, Ul. Novogireevskaya, Moscow, Russian Federation, 111123
E. I. Samokhvalov
Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federationканд. мед. наук, вед. науч. сотр. НИИ вирусологии им. Д.И. Ивановского, лаб. экологии вирусов Moscow, Russian Federation, 16, Ulitsa Gamalei, 123098
S. V. Al’khovsky
Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federationканд. биол. наук, зав. лаб. НИИ вирусологии им. Д.И. Ивановского, лаб. биотехнологии Moscow, Russian Federation, 16, Ulitsa Gamalei, 123098
A. E. Grishechkin
Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federationнауч. сотр. НИИ вирусологии им. Д.И. Ивановского, лаб. генно-инженерных препаратов Moscow, Russian Federation, 16, Ulitsa Gamalei, 123098
N. M. Belyaeva
State Budgetary Educational Institution of Additional Professioinal Education Russian Medical Academy of Postgraduate Educationд-р мед. наук, проф., зав. каф. инфекционных болезней ГБОУ ДПО РМАПО 2/1, Ul. Barrikadnaya, Moscow, Russian Federation, 123995
R. A. Gibadulin
Federal State Budgetary Institution D.I. Ivanovsky Institute of Virology of the Ministry of Health and Social Development of the Russian Federationд-р мед. наук, проф., зав. лаб. НИИ вирусологии им. Д.И. Ивановского, лаб. генно-инженерных препаратов. Moscow, Russian Federation, 16, Ulitsa Gamalei, 123098
References
- Абдуллаев С.М., Балацкий А.В., Ефименко А.Ю. Полиморфизм гена HFE как фактор прогрессирования фиброза у больных русской этнической принадлежности // Вестн. РГМУ - 2006. - № 2. - C. 49-54.
- Белобородова Е.В. Поражение печени при хронических вирусных гепатитах и их сочетание с алкогольной болезнью и опийной наркоманией. Автореф. дис.. д-ра мед. наук. -томск, 2007.
- Гончарова И.А., Белобородова Е.В., Фрейдин М.Б. и др. Ассоциации полиморфизмов генов иммунной системы с количественными признаками, генетически значимыми для хронических гепатитов // Молекул. биол. - 2008. - т. 42., № 2. - C. 242-246.
- Лавров А.В. Молекулярно-генетическая характеристика наследственного гемахроматоза у российских больных. Автореф. дис. канд. мед. наук. - М., 2004.
- Николаева Л.И., Зверев С.Я., Петрова Е.В. и др. Гуморальный ответ на антигены вируса гепатита C при коинфициро-вании вирусом иммунодефицита человека 1-го типа // Лаб. диагн. - 2008. - № 7. - C. 42-44.
- Николаева Л.И., Самоходская Л.М., Макашова В.В. и др. Поиск генетических факторов вируса гепатита C у пациентов с хроническим гепатитом С, ассоциированных с формированием устойчивого вирусологического ответа на противовирусную терапию // В мире вирус. гепатит. - 2011. - № 1. - C. 26-35.
- Самоходская Л.М., Лавров А.В., Ефименко А.Ю. и др. Особенности генетики наследственного гемахроматоза в русской популяции // Мед. генет. - 2007. - № 1. - С. 32-35.
- Самоходская Л.М., Игнатова Т.М., Абдуллаев С.М. и др. Прогностическое значение комбинации аллельных вариантов генов цитокинов и гемохроматоза у больных хроническим гепатитом C // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2007. - № 2. - С. 50-56.
- Семенова Н.А. Роль полиморфизмов генов apoE, HFE, SOD2 и IL-6 в патогенезе хронического гепатита C // Автореф. дис.. канд. мед. наук. - Томск, 2010.
- Bataller R., Schwabe R.F., Choi Y.H. et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis // J. Clin. Invest. - 2003. - Vol. 112. - P. 1383-1394.
- Bonkovsky H.L., Naishadham D., Lambrecht R.W. et al. HALT-C Trial Group. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C // Gastroenterology. - 2006. - Vol. 131. - P. 1440-1451.
- Bruno S., Crosignani A., Maisonneuve P. et al. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study // Hepatology. - 2007. - Vol. 46. - P. 1350-1356.
- Chisari F.V Unscrambling hepatitis C virus-host interactions // Nature. - 2005. - Vol. 436. - P. 930-932.
- Сonstantini P.K., Wawrzynowicz-Syczewska M., Clare M. et al. Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alphainterferon therapy // Liver. - 2002. - Vol. 22. - P. 404-412.
- Corengia C., Galimberti S., Bovo G. et al. Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course // Am. J. Clin. Pathol. - 2005. - Vol. 124. - P. 846-853.
- De Nicola S., Aghemo A., Rumi M.G., Colombo M. HCV genotype 3a: an independent predictor of fibrosis progression in chronic hepatitis C // J. Hepatol. - 2009. - Vol. 51. - P. 964-966.
- Di Marco V, Bronte F., Calvaruso V. et al. IL-28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection // Haematologica. - 2012. - Vol. 97. - P. 679-686.
- Dostalikova-Cimburova M., Kratka K., Stransky J. et al. Iron overload and HFE gene mutation in Czech patients with chrinic liver diseases. // Dis. Markers. - 2012. - Vol. 32. - P. 65-72.
- Eurich D., Bahra M., Boas-Knoop S. et al. Transforming growth factor beta1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus-induced liver disease // Liver Transplant. - 2011. - Vol. 17. - P. 279-288.
- Fabris C, Falleti E., Cussigh A. et al. IL-28B rs12979860 C/Т allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC // J. Hepatol. -2011. - Vol. 54. - P. 712-722.
- Falleti E., Fabris C., Toniotto P. et al. Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C // J. Interferon Cytokine Res. - 2007. - Vol. 27. - P. 239-246.
- Falleti E., Fabris C., Vandelli C. et al. Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C // Hum. Immunol. - 2010. - Vol. 71. - P. 999-1004.
- Farci P., Strazzera R., Alter H. J. et al. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome // Proc. Natl. Acad. Sci. USA. - 2002. - Vol. 99. - P. 3081-3086.
- Fishman D., Faulds G., Jeffery R. et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis // J. Clin. Invest. - 1998. - Vol. 102. - P. 1369-1376.
- Gattoni A., Parlato A., Vangieri B. et al. Role of hemochromatosis genes in chronic hepatitis C // Clin. Ter. - 2006. - Vol. 157. - P. 61-68.
- Gehrke S.G., Stremmel W., Mathes I. et al. Hemochromatosis and transferrin gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype // J. Mol. Med. - 2003. -Vol. 81. - P. 780-787.
- Gharib A.F., Karam R.A., Pasha H.F. et al. Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma // Gene. - 2011. - Vol. 489. - P. 98-102.
- Halfon P., Bourliere M., Ouzan D. et al. A single IL-28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 // Eur. J. Gastroenterol. Hepatol. - 2010. - Vol. 23. - P. 931-935.
- Hohler T., Kruger A., Gerken G. et al. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection // J. Med. Virol. - 1998. - Vol. 54. - P. 173-177.
- Lebray P., Zylberberg H., Hue S. et al. Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C // J. Viral. Hepat. -2004. - Vol. 1. - P. 175-182.
- Lvov D.K., Samokhvalov E.I., Tsuda F. et al. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia // Arch. Virology. - 1996. -Vol. 141. - P. 1613-1622.
- McNaughton L., Puttagunta L., Martinez-Cuesta M.A. et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver // Proc. Natl Acad. Sci. USA. - 2002. - Vol. 99. - P. 17161-17166.
- Pacal L., Husa P., Znojil V, Kankona K. HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech population // Hepat. Res. - 2007. - Vol. 37. - P. 740-747.
- Pereira F.A., Pinheiro da Silva N.N., Rodart I.F. et al. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection // J. Med. Virol. - 2008. - Vol. 80. - P. 58-64.
- Pestka S., Krause C.D., Sarkar D. et al. Interleukin-10 and related cytokines and receptors // Annu. Rev. Immunol. - 2004. - Vol. 22. -P. 929-979.
- Powell E.E., Edwards-Smith C.J., Hay J.L., et al. Host genetic factors influence disease progression in chronic hepatitis C // Hepatol-ogy. - 2000. - Vol. 31. - P. 828-833.
- Richardson M.M., Powell E.E., Barrie H.D. et al. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C virus // J. Med. Genet. - 2005. - Vol. 42 (e. 45). - P. 1-6.
- Simmonds P., Bukh J., Combet C. et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes // He-patology. - 2005. - Vol. 42. - P. 962-973.
- Tanaka Y., Furuta T., Suzuki S. et al. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan // J. Infect. Dis. - 2003. - Vol. 187. - P. 1822-1825.
- Thomas D.L., Thio C.L., Martin M.P. et al. Genetic variation in IL- 28B and spontanepus clearance of hepatitis C virus // Nature. - 2009. - Vol. 461. - P. 798-801.
- Viazov S., Ross S.S., Kyuregyan K.K. et al. Hepatitis C virus are rare even among intravenous drug users // J. Med. Virol. - 2010. - Vol. 82. - P. 232-238.